• Publications
  • Influence
Factors determining the remission of microprolactinomas after dopamine agonist withdrawal
Background  Withdrawal of dopamine agonist (DA) therapy in the management of microprolactinoma is common practice, but it is unclear which patients are likely to attain long‐term remission.
Co-morbidities, management and clinical outcome of auto-immune Addison’s disease
TLDR
A retrospective, cohort study of adults with primary adrenal failure shows a high prevalence of both auto-immune and non-autoimmune co-morbidities in patients with AAD, and patients should be screened for other cardiovascular risk factors.
Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.
TLDR
When injected subcutaneously into normal human subjects, Bl-T4-Ins is well tolerated, quickly absorbed, and highly protein bound, resulting in a long plasma halflife, and has the potential to provide more physiological insulin action than the insulin preparations currently used.
A survey of dopamine agonist withdrawal policy in UK endocrinologists treating patients with prolactinomas
TLDR
Whether or not DA therapy is withdrawn routinely and, if so, upon what criteria this is based and whether or not they felt that the current evidence to support this was good was good is surveyed.
Novel Hepatoselective Insulin Analog
TLDR
Osob zdrowych osob otrzymywalo podskornie Na B1L-thyroksyl-insuline (B1-T4-Ins) lub insuline NPH w przypadkowej kolejności wykazuje wzglednie wybiorcze powinowactwo do wątroby u ludzi.
Thomas Addison's disease after 154 years: modern diagnostic perspectives on an old condition.
TLDR
From the same institution where Thomas Addison performed his original autopsy studies, four recent cases highlighting the wide clinical spectrum and how modern biochemical and immunological tests could be utilized in early diagnosis and aetiological classification are presented.
Management of the Pregnant Diabetic Patient
SummaryThe prognosis in diabetic pregnancy has greatly improved as a result of patient education and the availability of home blood glucose monitoring techniques enabling the implementation of good